The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.

Swimming can help relieve the joint pain and stiffness you may experience with rheumatoid arthritis (RA). It can also help protect your joints through strengthening your muscles. The America Heart ...

Rheumatoid arthritis is an autoimmune disease that is characterized by inflammation of the joints and the subsequent destruction of cartilage and erosion of the bone. Patients with rheumatoid ...

The FDA has approved Celltrion’s similar of Genentech’s Actemra (tocilizumab). Celltrion’s Avtozma (tocilizumab-anoh) will be available as both an intravenous (IV) and subcutaneous (SC) formulations ...

Department of Thoracic Oncology, Jiangxi Cancer Hospital & Institute, Jiangxi Clinical Research Center for Cancer, The second Affiliated Hospital of Nanchang Medical College, Nanchang, China ...

Findings showed tocilizumab-anoh had comparable efficacy ... Avtozma is supplied as a preservative-free solution in 20mg/mL single-dose vials (80mg/4mL, 200mg/10mL, 400mg/20mL) for intravenous ...

The FDA approved Avtozma, a tocilizumab biosimilar developed by Celltrion, for the treatment of several rheumatic conditions. It is the third biosimilar to reference Actemra (tocilizumab) to be ...

Celltrion’s Avtozma has been indicated for the treatment of giant cell arteritis, polyarticular juvenile idiopathic arthritis, rheumatoid arthritis, systemic juvenile idiopathic arthritis, and ...

The University of Oxford or Oxford University is the oldest English-speaking institution of higher learning world-wide. Oxford University traces its roots to the 12th Century, but traces of it go ...